# China NMPA Drug Inspection - Yangtze River Pharmaceutical (Group) Co., Ltd. - Cefaclor Extended-Release Capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/yangtze-river-pharmaceutical-group-co-ltd/842c83f5-da31-497a-ba92-5c4b822feda6/
Source feed: China

> China NMPA drug inspection for Yangtze River Pharmaceutical (Group) Co., Ltd. published October 19, 2018. Drug: Cefaclor Extended-Release Capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 No. 7 Drug Supervision and Sampling Inspection Information Announcement
- Company Name: Yangtze River Pharmaceutical (Group) Co., Ltd.
- Publication Date: 2018-10-19
- Drug Name: Cefaclor Extended-Release Capsules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/yangtze-river-pharmaceutical-group-co-ltd/4758b09d-0a30-4746-b0e0-a55f6d216919/